Daniel H. Ahn, DO, discusses updated findings from the phase 3 KEYNOTE-177 trial in patients with newly diagnosed microsatellite instability–high/mismatch repair deficient metastatic colorectal cancer.
Up-to-date medical news aggregated from trusted medical associations, journals, physicians and news outlets from around the world.